Orthognathic surgery in patients treated with bisphosphonates: A case series

[1]  E. Carlson,et al.  American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update. , 2022, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[2]  Hyo-Jung Lee,et al.  Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis , 2021, Frontiers in Endocrinology.

[3]  A. Munz,et al.  Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis. , 2021, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[4]  J. Zöller,et al.  Bisphosphonate application and volumetric effects on MRONJ lesions. , 2021, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[5]  V. Patel,et al.  Preventing medication-related osteonecrosis of the jaw , 2019, BMJ.

[6]  R. Friedrich,et al.  The effect of bisphosphonate medication on orthodontics and orthognathic surgery in patients with osteogenesis imperfecta , 2019, GMS Interdisciplinary plastic and reconstructive surgery DGPW.

[7]  G. Warfvinge,et al.  Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[8]  M. Zandi,et al.  Evaluation of mandibular fracture healing in rats under zoledronate therapy: A histologic study. , 2017, Injury.

[9]  L. Mezzomo,et al.  The risk of osteonecrosis on alveolar healing after tooth extraction and systemic administration of antiresorptive drugs in rodents: a systematic review. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[10]  F. Neukam,et al.  Consultation with a specialized pain clinic reduces pain after oral and maxillofacial surgery. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[11]  T. Ettl,et al.  Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws. , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[12]  M. Ehrenfeld,et al.  Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study. , 2016, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[13]  L. Lima,et al.  Bisphosphonate treatment and dental implants: A systematic review , 2016, Medicina oral, patologia oral y cirugia bucal.

[14]  S. Pandian,et al.  Effect of bisphosphonates on orthodontic tooth movement-an update. , 2015, Journal of clinical and diagnostic research : JCDR.

[15]  B. Hohlweg-Majert,et al.  Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[16]  T. Dodson,et al.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. , 2014, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  W. Zemann,et al.  The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of “phossy” and “bisphossy” jaw , 2014, Oral and Maxillofacial Surgery.

[18]  C. Scully,et al.  Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[19]  S. Belknap,et al.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. , 2013, The Journal of bone and joint surgery. American volume.

[20]  Katsu Takahashi,et al.  Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. , 2012, International journal of oral and maxillofacial surgery.

[21]  M. Mozzati,et al.  Tooth extraction in patients on zoledronic acid therapy. , 2012, Oral oncology.

[22]  R. F. Sirandoni,et al.  Orthognathic surgery in a patient with osteogenesis imperfecta: a case study , 2011 .

[23]  A. Rosén,et al.  Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. , 2011, International journal of oral and maxillofacial surgery.

[24]  M. Broome,et al.  [The return of phossy jaw?]. , 2008, Revue de Stomatologie et de Chirurgie Maxillo-Faciale.

[25]  R. Marx.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[26]  S. Kates,et al.  How do bisphosphonates affect fracture healing? , 2016, Injury.

[27]  K. Purmal,et al.  Oral Bisphosphonate and Orthognathic Surgery: A Case Report and Literature Review , 2014 .